First Time Loading...

Enovis Corp
NYSE:ENOV

Watchlist Manager
Enovis Corp Logo
Enovis Corp
NYSE:ENOV
Watchlist
Price: 51.27 USD -1.65% Market Closed
Updated: May 5, 2024
Section:
 

Relative Value

The Relative Value of one ENOV stock under the Base Case scenario is 93.27 USD. Compared to the current market price of 51.27 USD, Enovis Corp is Undervalued by 45%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ENOV Relative Value
Base Case
93.27 USD
Undervaluation 45%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.6
P/S
P/S
Price to Sales
1.6
vs History
85
vs Industry
55
Median 3Y
1.9
Median 5Y
1.9
Industry
2.4
Forward
1.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-37.2
Median 5Y
-37.2
Industry
23.4
Forward
19.3
More Details
20.7
P/OCF
P/OCF
Price to OCF
20.7
vs History
51
vs Industry
20
Median 3Y
22.4
Median 5Y
22.4
Industry
15.5
More Details
12.9
P/FCFE
P/FCFE
Price to FCFE
12.9
vs History
48
vs Industry
31
Median 3Y
13.1
Median 5Y
13.1
Industry
23.2
More Details
0.8
P/B
P/B
Price to Book Value
0.8
vs History
66
vs Industry
68
Median 3Y
0.9
Median 5Y
0.9
Industry
2.3
More Details
1.9
EV/S
EV/S
Enterprise Value to Sales
1.9
vs History
59
vs Industry
50
Median 3Y
2
Median 5Y
2
Industry
2.5
Forward
1.5
More Details
3.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.3
vs History
70
vs Industry
57
Median 3Y
3.5
Median 5Y
3.5
Industry
5.3
More Details
13.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
13.6
vs History
62
vs Industry
25
Median 3Y
14.7
Median 5Y
14.7
Industry
12.6
Forward
8.5
More Details
162.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
162.5
vs History
40
vs Industry
1
Median 3Y
-79.8
Median 5Y
-79.8
Industry
17.2
Forward
12.3
More Details
23.9
EV/OCF
EV/OCF
Enterprise Value to OCF
23.9
vs History
51
vs Industry
18
Median 3Y
25.6
Median 5Y
25.6
Industry
15.3
More Details
253
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
253
vs History
18
vs Industry
2
Median 3Y
-19.4
Median 5Y
-19.4
Industry
19.8
More Details
0.7
EV/IC
EV/IC
Enterprise Value to IC
0.7
vs History
51
vs Industry
68
Median 3Y
0.8
Median 5Y
0.8
Industry
2
More Details

Multiples Across Competitors

ENOV Competitors Multiples
Enovis Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Enovis Corp
NYSE:ENOV
2.8B USD 1.6 -84.2 13.6 162.5
US
Abbott Laboratories
NYSE:ABT
183.6B USD 4.6 32.6 19.2 28.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
135.3B USD 18.5 68.1 55.8 70
US
Stryker Corp
NYSE:SYK
125.1B USD 6 37.2 24.2 29.7
IE
Medtronic PLC
NYSE:MDT
108.6B USD 3.4 25.9 13.8 19.5
US
Boston Scientific Corp
NYSE:BSX
106.8B USD 7.3 60.5 30.8 45.5
US
Becton Dickinson and Co
NYSE:BDX
67.8B USD 3.5 55.6 18.6 39.4
DE
Siemens Healthineers AG
XETRA:SHL
57.9B EUR 2.7 38.1 18.3 30.9
US
Edwards Lifesciences Corp
NYSE:EW
51.3B USD 8.4 36.3 26.4 28.5
US
Dexcom Inc
NASDAQ:DXCM
50.8B USD 13.4 79.5 59.5 77.4
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
368.4B CNY 10.7 32.5 28.3 28.3

See Also

Summary
ENOV intrinsic value, competitors valuation, and company profile.
DCF Valuation
ENOV stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ENOV stock valuation using valuation multiples.
Wall Street Estimates
ENOV price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ENOV stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.